Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 7.86% is 19% below its 5-year average of 9.70%, around the middle of its 5-year range (3.94%–13.54%).
3.49% below its 12-month average of 8.14%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 10.82%.
NET PROFIT MARGIN
7.86%
NET PROFIT MARGIN AVG TTM
8.14%
NET PROFIT MARGIN AVG 3Y
9.03%
NET PROFIT MARGIN AVG 5Y
9.70%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-3.49%
CURRENT VS 3Y AVG
-12.98%
CURRENT VS 5Y AVG
-18.99%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
9.21%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
-14.61%
vs the sector median at left
GE HealthCare Technologies Inc.
Market Cap
$29.99B
Net Profit Margin
7.86%
TTM Avg
8.14%
3Y Avg
9.03%
5Y Avg
9.70%
Market Cap
$31.11B
Net Profit Margin
21.91%
TTM Avg
21.94%
3Y Avg
21.74%
5Y Avg
21.20%
Market Cap
$32.53B
Net Profit Margin
20.12%
TTM Avg
16.12%
3Y Avg
14.73%
5Y Avg
15.57%
Market Cap
$26.57B
Net Profit Margin
16.98%
TTM Avg
16.55%
3Y Avg
18.38%
5Y Avg
18.84%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| GE HealthCare Technologies Inc. (GEHC) | $29.99B | 7.86% | 8.14% | 9.03% | 9.70% |
| Zoetis Inc. (ZTS)vs › | $29.84B | 27.49% | 27.55% | 27.17% | 26.57% |
| Medline Inc. (MDLN)vs › | $29.72B | 2.31% | 4.39% | 2.42% | 2.42% |
| Centene Corp. (CNC)vs › | $30.75B | -2.63% | -0.70% | 0.29% | 0.65% |
| Mettler-Toledo International Inc. (MTD)vs › | $31.11B | 21.91% | 21.94% | 21.74% | 21.20% |
| Alcon Inc. (ALC)vs › | $31.83B | 5.92% | 9.84% | 8.46% | 5.10% |
| ResMed Inc. (RMD)vs › | $32.21B | 26.94% | 27.08% | 24.30% | 22.30% |
| DexCom, Inc. (DXCM)vs › | $32.53B | 20.12% | 16.12% | 14.73% | 15.57% |
| West Pharmaceutical Services, Inc. (WST)vs › | $26.57B | 16.98% | 16.55% | 18.38% | 18.84% |
| Quest Diagnostics Incorporated (DGX)vs › | $26.14B | 9.19% | 8.91% | 9.15% | 11.71% |
Operating Margin
12.7%
Net Profit Margin
7.9%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 10.82% |
| 2026-03-31 | 7.58% |
| 2025-12-31 | 3.94% |
| 2025-09-30 | 8.67% |
| 2025-06-30 | 9.71% |
| 2025-03-31 | 11.81% |
| 2024-12-31 | 13.54% |
| 2024-09-30 | 9.69% |
| 2024-06-30 | 8.84% |
| 2024-03-31 | 8.04% |
| 2023-12-31 | 7.74% |
| 2023-09-30 | 7.78% |
| 2023-06-30 | 8.68% |
| 2023-03-31 | 7.90% |
| 2022-12-31 | 11.22% |
| 2022-09-30 | 10.66% |
| 2022-06-30 | 10.82% |
| 2022-03-31 | 8.96% |
| 2021-12-31 | 12.29% |
| 2021-09-30 | 11.71% |
| 2021-06-30 | 13.37% |
| 2021-03-31 | 13.37% |
